spironolactoneqtprolongation

2003 · 被引用 196 次 — oral spironolactone resulted in a reduction in the resting corrected QT interval (QTc) and normalization of QT dispersion and the QT/RR slope in subjects ...

由 S Snitker 著作 · 2017 · 被引用 34 次 — Most of the QT prolongation associated with metolazone and furosemide, but not spironolactone, remained after adjustment for potassium and ...

由 AM Choy 著作 · 1997 · 被引用 233 次 — Conclusions Potentially arrhythmogenic QT abnormalities during quinidine treatment and in CHF can be nearly normalized by modest elevation of serum potassium.

由 KYK Wong 著作 · 2013 · 被引用 18 次 — Both amiloride and spironolactone significantly reduced QTc length and reduced a plasma biomarker of myocardial fibrosis in stroke survivors ...

由 M Akbulut 著作 · 2003 · 被引用 33 次 — Effects of Spironolactone and Metoprolol on QT. Dispersion in Heart Failere ... Normalisation of acquired QT prolongation in humans by intrave- nous potassium.

由 J Klimas 著作 · 2015 · 被引用 34 次 — Aldosterone antagonists, eplerenone in animals and spironolactone in humans, have been found to modulate the duration of the QT interval.

由 S Snitker 著作 · 2017 · 被引用 34 次 — Most of the QT prolongation associated with metolazone and furosemide, but not spironolactone, remained after adjustment for potassium and ...

由 SP Etheridge 著作 · 2003 · 被引用 196 次 — The improvement in repolarization parameters achieved in this study suggests that oral KCl and spironolactone may be effective adjunctive therapy, together with ...

由 PJ Schwartz 著作 · 被引用 3 次 — Acquired LQTS usually results from undesired QT prolongation and potential for QT-triggered arrhythmias by either QT-prolonging disease states, ...